$PBIO News - Pressure BioSciences and the Institute of Bioinformatics Announce Comprehensive Two Year Collaboration

One of India\'s Most Prestigious Not-for-Profit Scientific Research Organizations to Incorporate PBI\'s Patented PCT Platform in their Search for Molecular Biomarkers in a Number of Human Diseases and Disorders, Including Cancer and Stroke - SOUTH EASTON, Mass, - (http://www.financialnewsmedia.com News Alert) - Pressure BioSciences, Inc. (OTCQB: PBIO) (\"PBI\" and the \"Company\"), a leader in the development and sale of broadly enabling pressure cycling technology (\"PCT\")-based sample preparation solutions to the worldwide life sciences industry, today announced it has entered into a two-year collaboration with the Institute of Bioinformatics (\"IOB\") in Bangalore, India. The IOB is one of the most prestigious not-for-profit scientific research centers in India, and one of the more highly regarded proteomic research organizations worldwide. The IOB staff, which includes dozens of scientists with advanced degrees, have published several hundred scientific papers over the past decade, many with a strong focus in the areas of proteomics, genomics, and metabolomics.



The Founder and Director of the IOB is Akhilesh Pandey M.D., Ph.D. Currently, Dr. Pandey is a Professor at the Institute of Genetic Medicine and the Departments of Biological Chemistry, Oncology, and Pathology at the Johns Hopkins School of Medicine. Dr. Pandey has received numerous prestigious honors and awards during his career, including, most recently, the Era of Hope Scholar Award by the United States Department of Defense. This award is \"intended for exceptionally talented, early-career scientists who have demonstrated that they are the best and the brightest in their field(s) through extraordinary creativity, vision, and productivity, and who have shown a strong potential for leadership in the breast cancer community as well as a vision for the eradication of breast cancer.\"



Dr. Pandey commented: \"The preparation of samples for analysis is a crucial step in all research studies worldwide aimed at finding biomarkers for the detection, control, prevention, and/or cure of human diseases and disorders. The IOB has modern, well-equipped facilities; however, we are well aware that the quality of results from our state-of-the-art instruments depends to a great extent on the quality and uniformity of the preparation of the samples being analyzed. Consequently, we are always...